Peder Andersen
Chief Tech/Sci/R&D Officer bij BIOSERGEN AB
Oorsprong van het eerstegraads netwerk van Peder Andersen
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
University of Copenhagen
42
| College/University | Other Consumer Services | 42 |
10
| Public Company | Biotechnology | 10 |
| Private Company | Pharmaceuticals: Major | 9 | |
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway.
1
| Holding Company | Biotechnology | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Peder Andersen via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| NOVO NORDISK A/S | Pharmaceuticals: Major | Chief Executive Officer Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CBRAIN A/S | Packaged Software | Director/Board Member Director/Board Member | |
| VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
| JYSKE BANK A/S | Major Banks | Director/Board Member Director/Board Member | |
| DANSKE BANK A/S | Major Banks | Director of Finance/CFO President | |
| AP MOLLER MAERSK | Marine Shipping | Chairman Director of Finance/CFO | |
| CARLSBERG A/S | Beverages: Alcoholic | Director/Board Member Director/Board Member | |
| NTG NORDIC TRANSPORT GROUP A/S | Trucking | Public Communications Contact Corporate Officer/Principal Chairman Chairman | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Chairman Chief Executive Officer | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Miscellaneous | Chairman Corporate Officer/Principal Chief Executive Officer | |
| BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Danica Pension, Livsforsikringsaktieselskab
 Danica Pension, Livsforsikringsaktieselskab Investment ManagersFinance Danica Pension Livsforsikrings A/S is a pension fund management firm headquartered in Kongens Lyngby, Denmark. The firm is a wholly-owned subsidiary of Danske Bank A/S (CPH: DANSKE). They specialize in pensions, life insurance, and health insurance for individual clients. | Investment Managers | Chief Executive Officer Chairman | |
Ferring Pharmaceuticals A/S
 Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| Copenhagen Business School | College/University | Undergraduate Degree Graduate Degree Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| Scandinavian International Management Institute | College/University | Masters Business Admin Masters Business Admin | |
LEO Fondet
 LEO Fondet BiotechnologyHealth Technology LEO Fondet provides support for research in the fields of medicine, chemistry, and pharmacy. The company was founded on August 20, 1984 and is headquartered in Ballerup, Denmark. | Biotechnology | Chief Executive Officer Director/Board Member | |
StemCare A/S
 StemCare A/S BiotechnologyHealth Technology StemCare A/S operates as a private stem cell bank. The firm stores stem cells from umbilical cord blood. The company was founded by Sten Verland in 2003 and is headquartered in Gentofte, Denmark. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor Chief Executive Officer | |
Dilafor AB
 Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Chairman Chief Executive Officer | |
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Drugstore Chains | Director/Board Member Director/Board Member | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Chief Executive Officer Corporate Officer/Principal | |
| International Monetary Conference | Director/Board Member Corporate Officer/Principal | ||
BKG Pharma ApS
 BKG Pharma ApS Pharmaceuticals: MajorHealth Technology BKG Pharma ApS develops and commercializes novel antibiotics against multidrug-resistant bacteria. It conducts research and development on treatment for multi-resistant infections such as resistance to chemotherapy. The company was founded by Birgit K. Giwercman in 2004 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chief Executive Officer | |
MELITEK A/S
 MELITEK A/S Packaged SoftwareTechnology Services MELITEK A/S develops technologies for the pharmaceutical and medical device industry. It supplies new innovative and sustainable technologies, which offer their customers a number of advantages within areas of product innovation, process improvements, higher safety, and enhanced profitability. The company was founded in 1979 and is headquartered in Noerre Alslev, Denmark. | Packaged Software | Director/Board Member | |
| Pacco A/S | Director/Board Member | ||
Peri Danmark A/S
 Peri Danmark A/S Finance/Rental/LeasingFinance Part of PERI GmbH, Peri Danmark A/S is a Danish company that specializes in leasing formwork and scaffolding systems. | Finance/Rental/Leasing | Director/Board Member | |
| Totempo Biler | Director/Board Member | ||
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chairman Director/Board Member | |
| StemCare Danmark A/S | Director/Board Member Director/Board Member | ||
| Kellogg School of Management | College/University | Graduate Degree Doctorate Degree | |
| Forward Pharma USA, LLC | Director of Finance/CFO Comptroller/Controller/Auditor | ||
| Xilco Holding (CH) AG | Director/Board Member Director/Board Member | ||
| BKG Vet Pharma ApS | Chief Executive Officer | ||
| Unisense Holding A/S | Director/Board Member | ||
Blue Ocean Robotics ApS
 Blue Ocean Robotics ApS Industrial MachineryProducer Manufacturing Blue Ocean Robotics ApS develops and introduces market-ready robots for industry, healthcare, education, agriculture and construction. The company was founded by Claus Risager and is headquartered in Odense, Denmark. | Industrial Machinery | Corporate Officer/Principal | |
LEO Holding A/S (Denmark)
 LEO Holding A/S (Denmark) Financial ConglomeratesFinance LEO Holding A/S invests in company with interest in medical dermatology. The company was founded on November 29, 2017 and is headquartered in Copenhagen, Denmark. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Pharmaceuticals: Major | Chairman Director of Finance/CFO Director of Finance/CFO | |
| Dwork Webdesign | Corporate Officer/Principal |
Statistieken
Internationaal
| Denemarken | 39 |
| Verenigde Staten | 7 |
| Zweden | 5 |
| Zwitserland | 2 |
| Nederland | 2 |
Sectoraal
| Health Technology | 19 |
| Finance | 9 |
| Consumer Services | 4 |
| Technology Services | 3 |
| Transportation | 3 |
Operationeel
| Director/Board Member | 377 |
| Chairman | 149 |
| Corporate Officer/Principal | 113 |
| Independent Dir/Board Member | 75 |
| Chief Executive Officer | 58 |
Sterkste connecties
| Insiders | |
|---|---|
| Eivind Kolding | 50 |
| Arne Gerlyng-Hansen | 46 |
| Bo Jesper Hansen | 34 |
| Philip Baruch | 29 |
| Karen Smith | 29 |
| Mattias Klintemar | 28 |
| Claus Tycho Bræstrup | 27 |
| Niels Henrik Jensen | 26 |
| J. Buchi | 26 |
| Leif Vejhe Djurhuus | 25 |
| Thomas Dyrberg | 24 |
| Torsten Rüdiger Goesch | 23 |
| Lars Rebien Sørensen | 22 |
| Duncan Moore | 19 |
| Christian Clausen | 18 |
- Beurs
- Insiders
- Peder Andersen
- Bedrijfsconnecties
